Display options
Share it on

Ther Clin Risk Manag. 2015 Jun 04;11:901-3. doi: 10.2147/TCRM.S83322. eCollection 2015.

GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress.

Therapeutics and clinical risk management

Antonio Ceriello, Lucia La Sala, Valeria De Nigris, Gemma Pujadas, Maurizio Rondinelli, Stefano Genovese

Affiliations

  1. Institut d'Investigación Biomédiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain ; Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Hospital Clinic, Barcelona, Spain.
  2. Institut d'Investigación Biomédiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain.
  3. Department of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni (MI), Italy.

PMID: 26082639 PMCID: PMC4461018 DOI: 10.2147/TCRM.S83322

[No abstract available.]

References

  1. Clin Chim Acta. 2006 May;367(1-2):103-7 - PubMed
  2. Mt Sinai J Med. 2006 Nov;73(7):1024-8 - PubMed
  3. Diabetes Care. 2013 Aug;36(8):2346-50 - PubMed
  4. Circ Res. 2001 Jun 22;88(12):1291-8 - PubMed
  5. Dtsch Med Wochenschr. 2014 Oct;139(42):2123-6 - PubMed
  6. Acta Med Indones. 2014 Apr;46(2):83-9 - PubMed
  7. Cardiovasc Diabetol. 2013 Oct 28;12:156 - PubMed
  8. Circulation. 2003 Apr 1;107(12):1579-85 - PubMed

Publication Types